For the best experienceDownload the Mobile App
App Store Play Store
Eli Lilly says retatrutide shows more weight loss compared to Ozempic
Eli Lilly says retatrutide shows more weight loss compared to Ozempic
Eli Lilly says retatrutide shows more weight loss compared to Ozempic

Published on: 10/28/2026

This news was posted by Oregon Today News

Go To Business Place

Description

Eli Lilly's experimental drug retatrutide showed greater reduction in A1C and double the average weight loss in a head-to-head clinical study against Ozempic.

News Source : https://www.kgw.com/article/news/health/eli-lilly-retatruide-weight-loss-a1c-vs-ozempic/507-8e32f392-a509-4023-83b7-e23c9d0c97d1

Other Related News

10/28/2026

Records show executive pay soared as Medicine Wheel tapped into Medicaid while flying Nati...

10/28/2026

Four medical groups unveiled a lifelong heart health roadmap for women from first period t...

10/28/2026

An man reportedly entered an apartment in southeast Canby assaulted a 12-year-old child an...

10/28/2026

The campaign to defeat the proposed Eugene Clean Energy Fund has seen a surge in fundraisi...

ShoutoutGive Shoutout
500/500